Role of NFkB in an Animal Model of Complex Regional Pain Syndrome-type I (CRPS-I)

[1]  H. Troeger.  [Complex regional pain syndrome (CRPS)]. , 2010, Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V....

[2]  J. Phillips,et al.  UNRAVELLING THE PATHOPHYSIOLOGY OF COMPLEX REGIONAL PAIN SYNDROME: FOCUS ON SYMPATHETICALLY MAINTAINED PAIN , 2008, Clinical and experimental pharmacology & physiology.

[3]  M. Neurath,et al.  NF‐κB in inflammatory bowel disease , 2008, Journal of internal medicine.

[4]  T. Coderre,et al.  Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain. , 2008, The journal of pain : official journal of the American Pain Society.

[5]  S. Uwe.  Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks. , 2008, Biochemical pharmacology.

[6]  M. Millecamps,et al.  Rats with chronic post-ischemia pain exhibit an analgesic sensitivity profile similar to human patients with complex regional pain syndrome--type I. , 2008, European journal of pharmacology.

[7]  T. Mittlmeier,et al.  Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain , 2007, Neuroscience.

[8]  Ruhang Tang,et al.  Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. , 2007, The Annals of thoracic surgery.

[9]  Scott Boyer,et al.  Applied information retrieval and multidisciplinary research: new mechanistic hypotheses in Complex Regional Pain Syndrome , 2007, Journal of biomedical discovery and collaboration.

[10]  N. Frangogiannis.  Chemokines in ischemia and reperfusion , 2007, Thrombosis and Haemostasis.

[11]  Hideshige Moriya,et al.  Injection of Nuclear Factor-Kappa B Decoy into the Sciatic Nerve Suppresses Mechanical Allodynia and Thermal Hyperalgesia in a Rat Inflammatory Pain Model , 2006, Spine.

[12]  T. Sun,et al.  Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. , 2006, British journal of anaesthesia.

[13]  S. Jimenez,et al.  NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis , 2006 .

[14]  Guoqing Guo,et al.  Attitudes towards internet advertising: a cross-cultural study , 2006 .

[15]  T. Guo,et al.  Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I , 2006, Pain.

[16]  J. Kalita,et al.  Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. , 2006, QJM : monthly journal of the Association of Physicians.

[17]  Robert Newton,et al.  Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. , 2005, American journal of respiratory and critical care medicine.

[18]  S. Maier,et al.  Involvement of spinal cord nuclear factor κB activation in rat models of proinflammatory cytokine‐mediated pain facilitation , 2005, The European journal of neuroscience.

[19]  Guillermo M. Alexander,et al.  Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS , 2005, Pain.

[20]  Hartmut Goldschmidt,et al.  Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. , 2005, The New England journal of medicine.

[21]  A. Israël,et al.  Activation of NF-κB in the mouse spinal cord following sciatic nerve transection , 2005, Experimental Brain Research.

[22]  N. Fukuishi,et al.  INHIBITON OF NF-κB ACTIVATION DURING ISCHEMIA REDUCES HEPATIC ISCHEMIA/REPERFUSION INJURY IN RATS , 2005 .

[23]  Gary J. Bennett,et al.  Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-Type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat , 2004, Pain.

[24]  Xian Wang,et al.  Interleukin‐1β induces β‐calcitonin gene‐related peptide secretion in human type II alveolar epithelial cells , 2004 .

[25]  H. Lee,et al.  Spinal NF‐kB activation induces COX‐2 upregulation and contributes to inflammatory pain hypersensitivity , 2004, The European journal of neuroscience.

[26]  M. Karjalainen‐Lindsberg,et al.  Nuclear Factor- (cid:1) B Contributes to Infarction After Permanent Focal Ischemia , 2004 .

[27]  Gerd Geisslinger,et al.  Specific Inhibition of IκB Kinase Reduces Hyperalgesia in Inflammatory and Neuropathic Pain Models in Rats , 2004, The Journal of Neuroscience.

[28]  Jan Klein,et al.  Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1. , 2004, Immunology letters.

[29]  Frank Birklein,et al.  Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome , 2003, Experimental Neurology.

[30]  M. Davies,et al.  A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II , 2003, Pain.

[31]  S Schultze-Mosgau,et al.  Tissue hypoxia in complex regional pain syndrome , 2003, Pain.

[32]  D. Kuik,et al.  The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study , 2003, Pain.

[33]  F. W. Blaisdell,et al.  The Pathophysiology of Skeletal Muscle Ischemia and the Reperfusion Syndrome: A Review , 2002, Cardiovascular surgery.

[34]  P. Burkett,et al.  Recent Advances in Understanding NF-κB Regulation , 2002 .

[35]  Jan Klein,et al.  Evidence for local inflammation in complex regional pain syndrome type 1. , 2002, Mediators of inflammation.

[36]  Linda R Watkins,et al.  Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. , 2002, Physiological reviews.

[37]  E. Mazzon,et al.  Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation , 2002, British journal of pharmacology.

[38]  M. Schmelz,et al.  The important role of neuropeptides in complex regional pain syndrome , 2001, Neurology.

[39]  R. Morishita,et al.  NF-κB decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model , 2001 .

[40]  A. Farr,et al.  Inhibition of the initial wave of NF‐κB activity in rat muscle reduces ischemia/reperfusion injury , 2001, Muscle & nerve.

[41]  B. Neundörfer,et al.  Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS) , 2000, Pain.

[42]  Sachiko Hattori,et al.  High-glucose-induced nuclear factor κB activation in vascular smooth muscle cells , 2000 .

[43]  R. Yezierski,et al.  Cytokine involvement in dynorphin-induced allodynia , 2000, PAIN®.

[44]  E. Ho,et al.  Supplementation of N‐acetylcysteine inhibits NFκB activation and protects against alloxan‐induced diabetes in CD‐1 mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  Richard Kijowski,et al.  Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. , 1998, Acta orthopaedica Belgica.

[46]  F. Gabreëls,et al.  Complex regional pain syndrome type I (RSD) , 1998, Neurology.

[47]  J. Bauer,et al.  The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. , 1997, Journal of immunology.

[48]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[49]  A. Eschalier,et al.  A method to perform direct transcutaneous intrathecal injection in rats. , 1994, Journal of pharmacological and toxicological methods.

[50]  Choi Yoon,et al.  Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain , 1994, Pain.

[51]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[52]  A. Reiss,et al.  Syndrome , 1990, Biological Psychiatry.

[53]  T. Jessell.  PAIN , 1982, The Lancet.

[54]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[55]  S. Jimenez,et al.  NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. , 2006, Osteoarthritis and cartilage.

[56]  M. Mattson,et al.  Roles for NF-kappaB in nerve cell survival, plasticity, and disease. , 2006, Cell death and differentiation.

[57]  N. Fukuishi,et al.  Inhibiton of NF-kappaB activation during ischemia reduces hepatic ischemia/reperfusion injury in rats. , 2005, The Journal of toxicological sciences.

[58]  Xian Wang,et al.  Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human type II alveolar epithelial cells. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  P. Burkett,et al.  Recent advances in understanding NF-kappaB regulation. , 2002, Inflammatory bowel diseases.

[60]  R. Morishita,et al.  NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. , 2001, Neuroreport.

[61]  Y. Hattori,et al.  High-glucose-induced nuclear factor k B activation in vascular smooth muscle cells * , 2000 .

[62]  Xianglin Shi,et al.  New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. , 1999, Clinical chemistry.

[63]  D. Slaaf,et al.  Partial peripheral neuropathy and denervation induced adrenoceptor supersensitivity. Functional studies in an experimental model. , 1998, Acta orthopaedica Belgica.

[64]  M. Freeman.  The role of longitudinal tibial rotation in the replaced knee. , 1998, Acta orthopaedica Belgica.

[65]  C V Jongeneel,et al.  Regulation of the TNF alpha gene. , 1994, Progress in clinical and biological research.

[66]  Jongeneel Cv.  Regulation of the TNF alpha gene. , 1994 .

[67]  P. Sehgal,et al.  Regulation of IL6 gene expression. , 1992, Research in immunology.